GSK vs HRTX · P/E 13, $103.31B cap vs rev $72.4M
GlaxoSmithKline PLC ADR (GSK) versus Heron Therapeuti (HRTX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. HRTX currently screens at market cap $332.6M.
Not investment advice. Open the GSK and HRTX stock pages for the full models.
Not investment advice.